J Korean Med Assoc.  2005 Jan;48(1):82-87. 10.5124/jkma.2005.48.1.82.

Thimerosal in Vaccine and Risk Communication

• Sohn YM

• KMID: 1722083
• DOI: http://doi.org/10.5124/jkma.2005.48.1.82

Abstract

No abstract available.

Keyword

Vaccine risk communicaiton; Thimerosal; Mercury poisoning; Autism

MeSH Terms

Autistic Disorder
Mercury Poisoning
Thimerosal*
Thimerosal

Reference

3. Plotkin SA. Lessons learned concerning vaccine safety. Vaccine. 2002. 20:S16–S19.

4. Duclos P. How to improve communication on vaccine safety at international level? Vaccine. 2002. 20:S96–S97.

5. Siegrist CA, Desgrandchamps D, Heiniger U, Vaudaux B. How to improve communication on vaccine safety at the national level? Vaccine. 2002. 20:S98–S100.

6. Aston R. Analysis of factors influencing vaccine uptake from various perspectives. Vaccine. 2002. 20:S1.

7. Goldman LR, Shannon MW. Committee on Environmental Health. Technical report: Mercury in the environment: Implications for pediatricians. Pediatrics. 2001. 108:197–204.

8. Clarkson TW. Mercury: major issues in environmental health. Environ Health Perspect. 1993. 100:31–38.

9. Hoover AW, Goldwater LJ. Absorption and excretion of mercury in man X. Dental amalgam as a source of urinary mercury. Arch Environ Health. 1966. 12:506–508.

10. Clarkson TW. The toxicology of mercury. Crit Rev Clin Lab Sci. 1997. 34:369–403.

11. Harada M. Minamata disease: Methylmercury poisoning in Japan caused by environmental pollution. Crit Rev Toxicol. 1995. 25:1–24.

12. Bakir F, Damlugi SF, Amin-Zaki L, Murtadha M, Khalidi A, Doherty RA, et al. Methylmercury poisoning in Iraq. Science. 1973. 181:230–241.

13. Axton JMH. Six cases of poisoning after a parenteral organic mercurial compound (merthiolare). Postgrad Med J. 1972. 48:417–421.

14. Davison PW, Myeres GJ, Cox C, Axtell C, Shamlaye C, Clarkson TW, et al. Effects of prenatla and postnatal methylmercury exposure from fish consumption on neurodevelopment Outcomes at 66 months of age in the Seychelles child development study. JAMA. 1998. 280:701–707.

15. Grandjean P, Weihe P, White R, Debes F, Araki S, Dahl R, et al. Cognitive deficit in 7 year old children with prenatal exposure methylmercury. Neurotoxicol Teratol. 1997. 6:417–428.

16. CDC. Notice to Readers: Thimerosal in vaccines: A joint statement of the American Academy of Pediatrics and the Public Health Service. Morb Mort Wkly Rev. 1999. 48:563–565.

17. Faran DG, Prtchard JS, Clarkson TW, Greenwood MR. Organ mercury levels in infants with omphaloceles treated with organic mercurial antiseptic. Arch Dis Child. 1977. 52:962–964.

18. Lowell HJ, Burgess S, Shenoy S, Peter M, Howard TK. Mercury poisoning associated with hepatitis B Immunoglobulin. Lancet. 1996. 347:480.

19. Matheson DS, Clarkson TW, Gelfand EW. Mercury toxicity (acrodynia) induced by long-term injection of gammaglobulin. J Pediatr. 1980. 98:153–155.

20. Pfab R, Mückter H, Roider G, Zilker T. Clinical course of severe poisoning with thiomersal. J Toxicol Clin Toxicol. 1996. 34:453–460.

21. Geier DA, Geier MR. An assessment of the impact of thimerosal on childhood neurodevelopmental disorders. Pediatric Rehabilitation. 2003. 6:97–102.

22. Geier DA, Geier MR. A comparative evaluation of the effects of MMR immunization and mercury doses from thimerosal-containing childhood vaccines on the population prevalence of autism. Med Sci Monit. 2004. 10:PI33–PI39.

23. Geier MR, Geier DA. Neurodevelopmental disorders after thimerosal-containing vaccines: A brief communication. Exp Biol Med (Maywood). 2003. 228:660–664.

24. IOM(Insitutue of Medicine). Thimerosal-containing vaccines and neurodevelopmental disorders. 2001. Washington DC: National Academu Press.

25. Parker SK, Schwartz B, Todd J, Pickering LK. Thimerosal-containing vaccines and autistic spectrum disorder: a critical review of published original data. Pediatrics. 2004. 114:793–804.

26. Hornig M, Chian D, Villiers J, Soman A, Valdman O, Lipkin WI, et al. Neurotoxic effects of postnatal thimerosal are mouse strain-dependent. Molecular Psychiatry 9. 2004. advance on line publication. http://www.greeneidab.columbia.edu/pressreleases/Thimabstract%20IMFAR.pdf.

27. Committee on Infectious Diseases and Committee on Environmental Health. Thimerosal in vaccine-An interim report to clinicians. Pediatrics. 1999. 104:570–574.

28. Ball LK, Ball R, Pratt RD. An assessment of thimerosal use in childhood vaccines. Pediatrics. 2001. 107:1147–1154.